TumorGen, Inc.

TumorGen is fighting the root cause of cancer

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Founded November 2017
  • Employees 2
  • Incorporation Type C-corp
  • Website tumorgenmdx.com

Company Summary

TumorGen is focused on circulating cancer cell clusters, the drivers of metastasis. We want to stop the spreading of cancer. Our mission is to identify unique targets in cancer cell clusters and enable the discovery and development of anti-metastatic drugs that save patients’ lives. Our business model as a specialty CRO opens up new therapeutic markets and allows pre-clinical candidate drug validation, thus de-risking future clinical trials.

Team

  • CSO and Co-founder

    I am a biomedical scientist with >20 year research and drug discovery experience. I discovered the structure of CD44, one the most recognized biomarker of metastatic invasion and cancer stem cells. I bring excellent analytical skills and strong team leading experience to the team and have proven success in identifying and characterizing new therapeutic targets and translating that knowledge to novel therapeutic approaches.

  • Founder, CEO & President

    The death of my wife, mother of my 2 young sons from cancer, started 17 years of learning on how to stop this deadly disease. I have 20 years of experience solving complex biological problems by integrating the right technologies into new systems. I have successfully directed design and launch of molecular diagnostics systems working for Beckman, Gen-Probe, and Becton-Dickinson.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free